372 related articles for article (PubMed ID: 21569004)
21. Advances in the treatment of multiple myeloma.
Barlogie B; Jagannath S; Tricot G; Desikan KR; Fassas A; Siegel D
Adv Intern Med; 1998; 43():279-320. PubMed ID: 9506186
[No Abstract] [Full Text] [Related]
22. Recent advances in the management of multiple myeloma.
Kumar L; Verma R; Radhakrishnan VR
Natl Med J India; 2010; 23(4):210-8. PubMed ID: 21192514
[TBL] [Abstract][Full Text] [Related]
23. Supportive therapies in the management of myeloma.
Ludwig H;
Oncology (Williston Park); 2004 Mar; 18(3):295-6, 298. PubMed ID: 15065700
[No Abstract] [Full Text] [Related]
24. Current concepts of clinical management of multiple myeloma.
Pingali SR; Haddad RY; Saad A
Dis Mon; 2012 Apr; 58(4):195-207. PubMed ID: 22449368
[No Abstract] [Full Text] [Related]
25. Multiple myeloma presenting as plasmacytoma of the base of the skull.
Alegre A; Tomás JF; Pinilla I; Gil-Fernández JJ; Fernández-Rañada JM
Am J Hematol; 1996 May; 52(1):60-1. PubMed ID: 8638614
[No Abstract] [Full Text] [Related]
26. Multiple myeloma in the elderly.
Cohen HJ
Clin Geriatr Med; 1985 Nov; 1(4):827-55. PubMed ID: 3913521
[TBL] [Abstract][Full Text] [Related]
27. High-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with multiple myeloma and renal insufficiency.
Ballester OF; Tummala R; Janssen WE; Fields KK; Hiemenz JW; Goldstein SC; Perkins JB; Sullivan DM; Rosen R; Sackstein R; Zorsky P; Saez R; Elfenbein GJ
Bone Marrow Transplant; 1997 Oct; 20(8):653-6. PubMed ID: 9383228
[TBL] [Abstract][Full Text] [Related]
28. Multiple myeloma: managing a complex blood cancer.
Dowling M; Kelly M; Meenaghan T
Br J Nurs; 2016 Sep; 25(16):S18-28. PubMed ID: 27615537
[TBL] [Abstract][Full Text] [Related]
29. Multiple myeloma: recognition and management.
George ED; Sadovsky R
Am Fam Physician; 1999 Apr; 59(7):1885-94. PubMed ID: 10208707
[TBL] [Abstract][Full Text] [Related]
30. Molecular mechanisms of novel therapeutic approaches for multiple myeloma.
Hideshima T; Anderson KC
Nat Rev Cancer; 2002 Dec; 2(12):927-37. PubMed ID: 12459731
[TBL] [Abstract][Full Text] [Related]
31. [High-dose chemotherapy with autologous peripheral blood stem cell transplantation for the treatment of multiple myeloma refractory to conventional chemotherapy].
Shimokawa T; Kajiguchi T; Saito M; Kojima Y; Takeyama H
Gan To Kagaku Ryoho; 2003 Feb; 30(2):251-4. PubMed ID: 12610874
[TBL] [Abstract][Full Text] [Related]
32. "Should all eligible patients with multiple myeloma receive autologous stem-cell transplant as part of initial treatment?".
Moreau P; Rajkumar SV
Leuk Res; 2012 Jun; 36(6):677-81. PubMed ID: 22430045
[No Abstract] [Full Text] [Related]
33. Management of multiple myeloma.
Richards JD; Singer CR; Tobias JS
Br J Hosp Med; 1987 May; 37(5):437, 440-2. PubMed ID: 2437986
[TBL] [Abstract][Full Text] [Related]
34. Multiple myeloma.
Mehta GR; Suhail F; Haddad RY; Zalzaleh G; Lerma EV
Dis Mon; 2014 Oct; 60(10):483-8. PubMed ID: 25288376
[No Abstract] [Full Text] [Related]
35. Intravenous pamidronate for myeloma bone disease: can the dose be lowered?
Terpos E; Dimopoulos MA
Lancet Oncol; 2010 Oct; 11(10):913-4. PubMed ID: 20863760
[No Abstract] [Full Text] [Related]
36. Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation.
Wang S; Nademanee A; Qian D; Dagis A; Park HS; Fridey J; Smith E; Snyder D; Somlo G; Stein A; Rosenthal J; Falk P; Kogut N; Palmer J; Gaal K; Kim Y; Bhatia R; Yuan S; Kay C; Weiss L; Forman S
Transfusion; 2007 Dec; 47(12):2207-16. PubMed ID: 17714420
[TBL] [Abstract][Full Text] [Related]
37. Reversibility of renal impairment in patients with multiple myeloma treated with bortezomib-based regimens: identification of predictive factors.
Dimopoulos MA; Roussou M; Gavriatopoulou M; Zagouri F; Migkou M; Matsouka C; Barbarousi D; Christoulas D; Primenou E; Grapsa I; Terpos E; Kastritis E
Clin Lymphoma Myeloma; 2009 Aug; 9(4):302-6. PubMed ID: 19717380
[TBL] [Abstract][Full Text] [Related]
38. Guidelines on the diagnosis and management of chronic lymphocytic leukaemia.
Oscier D; Fegan C; Hillmen P; Illidge T; Johnson S; Maguire P; Matutes E; Milligan D;
Br J Haematol; 2004 May; 125(3):294-317. PubMed ID: 15086411
[No Abstract] [Full Text] [Related]
39. Strategies in treating newly diagnosed or untreated multiple myeloma patients. From the Multiple Myeloma Research Foundation.
Weber DM
Oncology (Williston Park); 2003 Jun; 17(6):765-7. PubMed ID: 12846120
[TBL] [Abstract][Full Text] [Related]
40. Thalidomide and dexamethasone in patients with multiple myeloma not undergoing upfront autologous stem cell transplantation.
Blade J
Haematologica; 2005 Dec; 90(12):1589. PubMed ID: 16330426
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
